HomeZTS • NYSE
add
Zoetis Inc
Previous close
$149.60
Day range
$148.75 - $151.74
Year range
$144.80 - $201.92
Market cap
68.94B USD
Avg Volume
4.12M
P/E ratio
29.76
Dividend yield
1.15%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.21B | 8.48% |
Operating expense | 776.00M | 11.33% |
Net income | 525.00M | 13.88% |
Net profit margin | 23.72 | 4.96% |
Earnings per share | 1.24 | 7.83% |
EBITDA | 763.00M | 2.01% |
Effective tax rate | 19.54% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.04B | -43.00% |
Total assets | 14.29B | -4.28% |
Total liabilities | 9.30B | -11.66% |
Total equity | 4.99B | — |
Shares outstanding | 457.87M | — |
Price to book | 13.72 | — |
Return on assets | 12.54% | — |
Return on capital | 15.03% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 525.00M | 13.88% |
Cash from operations | 897.00M | 21.05% |
Cash from investing | -210.00M | 52.05% |
Cash from financing | -397.00M | -150.90% |
Net change in cash | 287.00M | -73.28% |
Free cash flow | 750.12M | 20.31% |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
14,100